These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12448303)

  • 1. [Open report of the results in the VIGOR study. Clear evidence of effect and safety].
    Lilienberg E; Moan A
    Lakartidningen; 2002 Oct; 99(42):4197. PubMed ID: 12448303
    [No Abstract]   [Full Text] [Related]  

  • 2. [Financial interests characterize published reports on coxiber. Whom can we rely on?].
    Håkansson J
    Lakartidningen; 2002 Oct; 99(40):3930-1. PubMed ID: 12422746
    [No Abstract]   [Full Text] [Related]  

  • 3. [The CLASS study and its scientific statement. Ethical publishing rules neglected].
    Wollheim FA
    Lakartidningen; 2002 Oct; 99(40):3934-5. PubMed ID: 12422748
    [No Abstract]   [Full Text] [Related]  

  • 4. Scientific publishing. Echoing other cases, NEJM says Vioxx Safety data withheld.
    Couzin J
    Science; 2005 Dec; 310(5755):1755. PubMed ID: 16357236
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pfizer urged to respond to criticism and participate in the public debate].
    Bengt J
    Lakartidningen; 2005 Feb 21-27; 102(8):574-5. PubMed ID: 15786910
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recommendations for treatment with nonsteroidal anti-inflammatory drugs].
    Bolten WW
    MMW Fortschr Med; 2005 Aug; 147(31-32):24-7. PubMed ID: 16128192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Undesired effects of NSAIDS and coxibs].
    Fauler J
    MMW Fortschr Med; 2005 Aug; 147(31-32):31-5. PubMed ID: 16128194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety reporting in randomized clinical trials - a need for improvement.
    Yazici Y
    Bull NYU Hosp Jt Dis; 2009; 67(2):209-10. PubMed ID: 19583556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do financial factors such as author page charges and industry funding impact on the nature of published research in infectious diseases?
    Liyanage SS; Raina Macintyre C
    Health Info Libr J; 2006 Sep; 23(3):214-22. PubMed ID: 16911128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacia and Pfizer on the CLASS trial: criticism doesn't give a fair picture of the results].
    Andersson T; Frösing R
    Lakartidningen; 2002 Oct; 99(41):4086. PubMed ID: 12451957
    [No Abstract]   [Full Text] [Related]  

  • 11. Celecoxib and the CLASS trial: data massaging by industry.
    Prescrire Int; 2002 Dec; 11(62):190-1. PubMed ID: 12472103
    [No Abstract]   [Full Text] [Related]  

  • 12. [We must learn how to be better to evaluate drug benefits and risks].
    Dahl E
    Lakartidningen; 2005 Jun 27-Jul 10; 102(26-27):2003-4. PubMed ID: 16044759
    [No Abstract]   [Full Text] [Related]  

  • 13. [New substances need critical appraisal, unequivocal information and time. COX-2-inhibitors between cold facts and media hype].
    Stichtenoth DO
    MMW Fortschr Med; 2005 Aug; 147(31-32):23-4. PubMed ID: 16128191
    [No Abstract]   [Full Text] [Related]  

  • 14. The need for publishing the silent evidence from negative trials.
    Colom F; Vieta E
    Acta Psychiatr Scand; 2011 Feb; 123(2):91-4. PubMed ID: 21198451
    [No Abstract]   [Full Text] [Related]  

  • 15. What price pain relief?
    Hochman JS; Shah NR
    Circulation; 2006 Jun; 113(25):2868-70. PubMed ID: 16785335
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug research. Legislators propose a registry to track clinical trials from start to finish.
    Couzin J
    Science; 2004 Sep; 305(5691):1695. PubMed ID: 15375239
    [No Abstract]   [Full Text] [Related]  

  • 17. Publish or be damned.
    Vines G
    New Sci; 1997 Sep; 155(2099):53. PubMed ID: 16127834
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pain therapy in rheumatism. After 65 years of age coxibs are the best choice].
    MMW Fortschr Med; 2003 Oct; 145(42):60. PubMed ID: 14655447
    [No Abstract]   [Full Text] [Related]  

  • 19. [Selective reporting--greater problem than selective publishing?].
    Melander H
    Lakartidningen; 2005 Jan 24-30; 102(4):224-5. PubMed ID: 15743133
    [No Abstract]   [Full Text] [Related]  

  • 20. Industrial publication of controlled clinical trial data.
    Novack GD
    Clin Pharmacol Ther; 1993 Apr; 53(4):495-6; author reply 497. PubMed ID: 8477568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.